Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
As the marketing of soda and fast food ramps up around the world, the companies involved forge partnerships to help the poor. The new book 'Junk Food Politics' casts a critical eye at their efforts. -
People who lose track of time aren't rude, researchers say — they may just be listening to their inner timekeeper instead of an external clock. Living according to "event time" has its benefits.
-
In Fairfax County, Va., the health department is training high school students to become health ambassadors in underserved communities and get a leg up on future careers in public health.
-
The pandemic put infectious diseases doctors in the spotlight. The 'Fauci Effect' raised the number of fellowship applicants in 2020, but this year almost half of the training programs went unfilled.
-
The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
-
For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
-
The updated recommendations seek to course correct after guidelines from 2016 were criticized for harshly limiting access to needed pain medication.
-
Early fears of an escalating outbreak have not come to pass. Scientists are finding that the virus needs a very particular set of circumstances to spread effectively.
-
Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done.
-
Data shows that a disproportionate number of people who contract monkeypox are also HIV positive. Researchers are trying to figure out the reason.
